15 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
26572217	60	Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors.	Genentech
25611347	2	Quinofuracins A-E, produced by the fungus Staphylotrichum boninense PF1444, show p53-dependent growth suppression.	Institute of Microbial Chemistry (Bikaken)
23726034	117	Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation.	Novartis Institutes For Biomedical Research
22524527	13	Structure-based design of novel inhibitors of the MDM2-p53 interaction.	Amgen
19856920	10	Discovery and optimization of chromenotriazolopyrimidines as potent inhibitors of the mouse double minute 2-tumor protein 53 protein-protein interaction.	Amgen
30660827	70	Quinolone hybrids and their anti-cancer activities: An overview.	Qilu University of Technology (Shandong Academy of Sciences)
23075044	3	Small molecules that target protein misfolding.	Pfizer
30075999	11	Novel tertiary sulfonamides as potent anti-cancer agents.	Human Biomolecular Research Institute
29702446	25	Aminobenzothiazole derivatives stabilize the thermolabile p53 cancer mutant Y220C and show anticancer activity in p53-Y220C cell lines.	University of Southampton
28947947	112	Discovery of CDZ173 (Leniolisib), Representing a Structurally Novel Class of PI3K Delta-Selective Inhibitors.	Novartis Institutes For Biomedical Research